SIMILAR PATTERNS OF AMINO ACIDS FOR 6AGO_A_SAMA2301

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ii0 ARSENICAL
PUMP-DRIVING ATPASE

(Escherichia
coli) 		PF02374
(ArsA_ATPase) 		5 GLY A 178
ASP A 121
TYR A 186
CYH A 113
CYH A 172
 None
None
None
CD  A 594 (-2.4A)
CD  A 594 (-2.4A)
 1.23A 6agoA-1ii0A:
undetectable		 6agoA-1ii0A:
16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 ASP A 202
TYR A 204
HIS A 242
TYR A 283
CYH A 306
 SAH  A 319 (-3.6A)
SAH  A 319 (-4.0A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 ( 2.3A)
 0.97A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A 160
TRP A 161
ASN A 241
HIS A 242
CYH A 306
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.8A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
ZN  A   4 ( 2.3A)
 1.46A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A 160
TRP A 161
ASN A 241
HIS A 242
TYR A 283
CYH A 306
CYH A 308
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.8A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 ( 2.3A)
ZN  A   4 (-2.2A)
 0.79A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A 160
TRP A 161
HIS A 242
TYR A 283
CYH A 308
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.8A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 (-2.2A)
 1.39A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A 160
TYR A 204
ASN A 241
HIS A 242
TYR A 283
CYH A 306
CYH A 308
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.0A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 ( 2.3A)
ZN  A   4 (-2.2A)
 1.04A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 TRP A 161
ASP A 202
HIS A 242
TYR A 283
CYH A 306
 SAH  A 319 (-4.8A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 ( 2.3A)
 0.83A 6agoA-1pegA:
18.3		 6agoA-1pegA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x4l SKELETAL MUSCLE
LIM-PROTEIN 3

(Homo sapiens) 		PF00412
(LIM) 		5 ASN A  33
HIS A  32
CYH A   8
CYH A  35
ILE A  15
 None
ZN  A 201 (-3.1A)
ZN  A 201 (-2.3A)
ZN  A 201 (-2.2A)
None
 1.45A 6agoA-1x4lA:
undetectable		 6agoA-1x4lA:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes) 		PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2) 		5 GLY A 331
ASN A 323
TYR A 288
CYH A  16
ILE A 108
 None
 1.39A 6agoA-2bc0A:
undetectable		 6agoA-2bc0A:
17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dv6 NITRITE REDUCTASE

(Hyphomicrobium
denitrificans) 		PF07732
(Cu-oxidase_3) 		5 GLY A 309
ASP A 178
TYR A 325
TYR A 185
ILE A 145
 None
 1.27A 6agoA-2dv6A:
undetectable		 6agoA-2dv6A:
18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pie E3 UBIQUITIN-PROTEIN
LIGASE RNF8

(Homo sapiens) 		PF00498
(FHA) 		5 GLY A  45
ASN A  62
HIS A  63
CYH A  64
ILE A  59
 None
 1.40A 6agoA-2pieA:
undetectable		 6agoA-2pieA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A 151
TRP A 152
ASN A 219
HIS A 220
CYH A 287
 SAM  A 304 (-3.5A)
None
SAM  A 304 (-3.3A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
 1.30A 6agoA-2r3aA:
18.5		 6agoA-2r3aA:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A 151
TRP A 152
ASN A 219
HIS A 220
TYR A 261
CYH A 287
CYH A 289
 SAM  A 304 (-3.5A)
None
SAM  A 304 (-3.3A)
SAM  A 304 (-4.9A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
ZN  A 300 ( 2.3A)
 0.80A 6agoA-2r3aA:
18.5		 6agoA-2r3aA:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 TYR A 193
ASN A 219
HIS A 220
TYR A 261
CYH A 287
CYH A 289
 SAM  A 304 (-4.2A)
SAM  A 304 (-3.3A)
SAM  A 304 (-4.9A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
ZN  A 300 ( 2.3A)
 1.06A 6agoA-2r3aA:
18.5		 6agoA-2r3aA:
29.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5z HISTONE-LYSINE
N-METHYLTRANSFERASE
HRX

(Homo sapiens) 		PF00856
(SET) 		7 GLY A3840
TYR A3883
ASN A3906
HIS A3907
TYR A3944
CYH A3957
CYH A3959
 SAH  A4971 ( 3.7A)
None
SAH  A4971 (-3.1A)
SAH  A4971 (-4.7A)
SAH  A4971 (-4.9A)
ZN  A4970 ( 2.3A)
ZN  A4970 (-2.3A)
 1.02A 6agoA-2w5zA:
14.2		 6agoA-2w5zA:
25.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5z HISTONE-LYSINE
N-METHYLTRANSFERASE
HRX

(Homo sapiens) 		PF00856
(SET) 		5 GLY A3842
TYR A3883
HIS A3907
TYR A3944
CYH A3959
 None
None
SAH  A4971 (-4.7A)
SAH  A4971 (-4.9A)
ZN  A4970 (-2.3A)
 1.36A 6agoA-2w5zA:
14.2		 6agoA-2w5zA:
25.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A 136
TRP A 137
ASN A 209
HIS A 210
TYR A 248
CYH A 273
CYH A 275
 SAH  A 305 (-3.8A)
None
SAH  A 305 (-3.4A)
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
ZN  A 304 ( 2.3A)
 0.89A 6agoA-3bo5A:
19.2		 6agoA-3bo5A:
28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A 136
TYR A 178
ASN A 209
HIS A 210
TYR A 248
CYH A 273
CYH A 275
 SAH  A 305 (-3.8A)
SAH  A 305 (-4.0A)
SAH  A 305 (-3.4A)
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
ZN  A 304 ( 2.3A)
 0.94A 6agoA-3bo5A:
19.2		 6agoA-3bo5A:
28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A 138
TYR A 178
HIS A 210
TYR A 248
CYH A 273
CYH A 275
 None
SAH  A 305 (-4.0A)
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
ZN  A 304 ( 2.3A)
 1.43A 6agoA-3bo5A:
19.2		 6agoA-3bo5A:
28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 LYS A 135
GLY A 136
TRP A 137
ASN A 209
CYH A 275
 None
SAH  A 305 (-3.8A)
None
SAH  A 305 (-3.4A)
ZN  A 304 ( 2.3A)
 1.39A 6agoA-3bo5A:
19.2		 6agoA-3bo5A:
28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 LYS A 135
GLY A 136
TYR A 178
ASN A 209
CYH A 275
 None
SAH  A 305 (-3.8A)
SAH  A 305 (-4.0A)
SAH  A 305 (-3.4A)
ZN  A 304 ( 2.3A)
 1.39A 6agoA-3bo5A:
19.2		 6agoA-3bo5A:
28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3chl ALPHA-14 GIARDIN

(Giardia
intestinalis) 		PF00191
(Annexin) 		5 GLY A 259
ASP A 261
TYR A 303
CYH A 295
ILE A 307
 None
 1.40A 6agoA-3chlA:
undetectable		 6agoA-3chlA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  16
ASN A 205
HIS A 206
TYR A 252
CYH A 274
 None
SFG  A 491 (-3.3A)
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 1.26A 6agoA-3n71A:
6.0		 6agoA-3n71A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  16
HIS A 206
TYR A 252
CYH A 274
CYH A 276
 None
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
ZN  A 497 (-2.5A)
 0.97A 6agoA-3n71A:
6.0		 6agoA-3n71A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  18
ASN A 205
HIS A 206
TYR A 252
CYH A 274
 SFG  A 491 ( 4.2A)
SFG  A 491 (-3.3A)
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 0.92A 6agoA-3n71A:
6.0		 6agoA-3n71A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  18
ASN A 205
HIS A 206
TYR A 252
CYH A 274
 SFG  A 491 ( 4.2A)
SFG  A 491 (-3.3A)
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 1.31A 6agoA-3n71A:
6.0		 6agoA-3n71A:
18.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		5 GLY A 102
TRP A 103
ASN A 169
HIS A 170
CYH A 219
 SAM  A 237 ( 3.7A)
None
SAM  A 237 (-3.3A)
SAM  A 237 (-4.7A)
ZN  A 232 ( 2.3A)
 1.46A 6agoA-3ooiA:
25.0		 6agoA-3ooiA:
43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		7 GLY A 102
TRP A 103
ASN A 169
HIS A 170
TYR A 207
CYH A 219
CYH A 221
 SAM  A 237 ( 3.7A)
None
SAM  A 237 (-3.3A)
SAM  A 237 (-4.7A)
None
ZN  A 232 ( 2.3A)
ZN  A 232 (-2.3A)
 0.93A 6agoA-3ooiA:
25.0		 6agoA-3ooiA:
43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		7 GLY A 102
TYR A 146
ASN A 169
HIS A 170
TYR A 207
CYH A 219
CYH A 221
 SAM  A 237 ( 3.7A)
SAM  A 237 (-4.1A)
SAM  A 237 (-3.3A)
SAM  A 237 (-4.7A)
None
ZN  A 232 ( 2.3A)
ZN  A 232 (-2.3A)
 0.82A 6agoA-3ooiA:
25.0		 6agoA-3ooiA:
43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		5 GLY A 104
TYR A 146
HIS A 170
TYR A 207
CYH A 221
 None
SAM  A 237 (-4.1A)
SAM  A 237 (-4.7A)
None
ZN  A 232 (-2.3A)
 1.50A 6agoA-3ooiA:
25.0		 6agoA-3ooiA:
43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		8 GLY A2151
ASP A2192
TYR A2194
HIS A2218
TYR A2255
CYH A2268
CYH A2270
ILE A2279
 SAM  A   7 (-3.4A)
SAM  A   7 (-3.9A)
SAM  A   7 (-3.4A)
None
None
ZN  A   1 ( 2.5A)
ZN  A   1 (-2.7A)
None
 0.81A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 GLY A2151
TRP A2152
ASN A2217
HIS A2218
CYH A2268
 SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
None
ZN  A   1 ( 2.5A)
 1.33A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		8 GLY A2151
TRP A2152
ASN A2217
HIS A2218
TYR A2255
CYH A2268
CYH A2270
ILE A2279
 SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
None
None
ZN  A   1 ( 2.5A)
ZN  A   1 (-2.7A)
None
 0.73A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		8 GLY A2151
TRP A2152
ASP A2192
HIS A2218
TYR A2255
CYH A2268
CYH A2270
ILE A2279
 SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
None
None
ZN  A   1 ( 2.5A)
ZN  A   1 (-2.7A)
None
 0.76A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 GLY A2151
TRP A2152
HIS A2218
TYR A2255
CYH A2270
 SAM  A   7 (-3.4A)
None
None
None
ZN  A   1 (-2.7A)
 1.48A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		8 GLY A2151
TYR A2194
ASN A2217
HIS A2218
TYR A2255
CYH A2268
CYH A2270
ILE A2279
 SAM  A   7 (-3.4A)
SAM  A   7 (-3.4A)
SAM  A   7 (-3.9A)
None
None
ZN  A   1 ( 2.5A)
ZN  A   1 (-2.7A)
None
 0.83A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		7 GLY A2153
TYR A2194
HIS A2218
TYR A2255
CYH A2268
CYH A2270
ILE A2279
 None
SAM  A   7 (-3.4A)
None
None
ZN  A   1 ( 2.5A)
ZN  A   1 (-2.7A)
None
 1.44A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 LYS A2150
GLY A2151
ASP A2192
TYR A2194
CYH A2270
 None
SAM  A   7 (-3.4A)
SAM  A   7 (-3.9A)
SAM  A   7 (-3.4A)
ZN  A   1 (-2.7A)
 1.32A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 LYS A2150
GLY A2151
TRP A2152
ASN A2217
CYH A2270
 None
SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
ZN  A   1 (-2.7A)
 1.27A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 LYS A2150
GLY A2151
TRP A2152
ASP A2192
CYH A2270
 None
SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
ZN  A   1 (-2.7A)
 1.17A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 LYS A2150
GLY A2151
TYR A2194
ASN A2217
CYH A2270
 None
SAM  A   7 (-3.4A)
SAM  A   7 (-3.4A)
SAM  A   7 (-3.9A)
ZN  A   1 (-2.7A)
 1.32A 6agoA-3opeA:
30.1		 6agoA-3opeA:
86.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4au7 HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H2

(Mus musculus) 		PF00856
(SET) 		5 ASN A 182
HIS A 183
TYR A 217
CYH A 229
CYH A 231
 SAH  A1247 (-3.1A)
SAH  A1247 (-4.6A)
None
ZN  A1248 ( 2.3A)
ZN  A1248 ( 2.2A)
 0.84A 6agoA-4au7A:
8.2		 6agoA-4au7A:
23.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A1561
TRP A1562
HIS A1629
CYH A1678
CYH A1680
 0UM  A1804 (-3.5A)
None
None
ZN  A1803 ( 2.2A)
ZN  A1803 (-2.2A)
 0.83A 6agoA-4fmuA:
23.8		 6agoA-4fmuA:
38.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A1561
TYR A1605
HIS A1629
CYH A1678
CYH A1680
 0UM  A1804 (-3.5A)
0UM  A1804 (-4.2A)
None
ZN  A1803 ( 2.2A)
ZN  A1803 (-2.2A)
 0.50A 6agoA-4fmuA:
23.8		 6agoA-4fmuA:
38.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		5 TRP A1562
ASN A1628
HIS A1629
CYH A1678
CYH A1680
 None
0UM  A1804 (-3.3A)
None
ZN  A1803 ( 2.2A)
ZN  A1803 (-2.2A)
 0.97A 6agoA-4fmuA:
23.8		 6agoA-4fmuA:
38.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		5 TYR A1605
ASN A1628
HIS A1629
CYH A1678
CYH A1680
 0UM  A1804 (-4.2A)
0UM  A1804 (-3.3A)
None
ZN  A1803 ( 2.2A)
ZN  A1803 (-2.2A)
 0.86A 6agoA-4fmuA:
23.8		 6agoA-4fmuA:
38.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hpf POTASSIUM CHANNEL
SUBFAMILY U MEMBER 1

(Homo sapiens) 		PF03493
(BK_channel_a) 		5 GLY A 755
ASP A 785
TYR A 782
CYH A 797
ILE A 824
 None
 1.49A 6agoA-4hpfA:
undetectable		 6agoA-4hpfA:
15.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mi5 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A 628
TRP A 629
ASN A 693
HIS A 694
TYR A 731
 None
 0.80A 6agoA-4mi5A:
15.0		 6agoA-4mi5A:
30.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		8 GLY A 457
TRP A 458
TYR A 493
ASN A 551
HIS A 552
TYR A 593
CYH A 612
CYH A 614
 SAH  A 801 (-3.6A)
SAH  A 801 (-4.9A)
SAH  A 801 (-4.0A)
SAH  A 801 (-3.2A)
None
None
ZN  A 805 ( 2.4A)
ZN  A 805 ( 2.4A)
 0.76A 6agoA-4qeoA:
16.9		 6agoA-4qeoA:
21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		6 LYS A 456
GLY A 457
TRP A 458
TYR A 493
ASN A 551
CYH A 614
 SAH  A 801 (-4.7A)
SAH  A 801 (-3.6A)
SAH  A 801 (-4.9A)
SAH  A 801 (-4.0A)
SAH  A 801 (-3.2A)
ZN  A 805 ( 2.4A)
 1.13A 6agoA-4qeoA:
16.9		 6agoA-4qeoA:
21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		5 LYS A 456
GLY A 457
TRP A 458
TYR A 493
CYH A 614
 SAH  A 801 (-4.7A)
SAH  A 801 (-3.6A)
SAH  A 801 (-4.9A)
SAH  A 801 (-4.0A)
ZN  A 805 ( 2.4A)
 1.42A 6agoA-4qeoA:
16.9		 6agoA-4qeoA:
21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w2r ENHANCER OF ZESTE 2
POLYCOMB REPRESSIVE
COMPLEX 2 SUBUNIT

(Anolis
carolinensis) 		no annotation 5 GLY A 520
TRP A 521
ASN A 585
HIS A 586
TYR A 623
 CJD  A 708 (-3.6A)
None
CJD  A 708 (-3.5A)
None
None
 0.82A 6agoA-4w2rA:
21.0		 6agoA-4w2rA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z4p HISTONE-LYSINE
N-METHYLTRANSFERASE
2D

(Homo sapiens) 		PF00856
(SET) 		7 GLY A5408
TYR A5451
ASN A5474
HIS A5475
TYR A5512
CYH A5525
CYH A5527
 SAH  A5602 (-3.6A)
SAH  A5602 (-4.5A)
SAH  A5602 (-3.1A)
None
None
ZN  A5601 ( 2.2A)
ZN  A5601 ( 2.2A)
 0.81A 6agoA-4z4pA:
15.6		 6agoA-4z4pA:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cpr HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1

(Homo sapiens) 		PF00856
(SET) 		5 ASN B 272
HIS B 273
TYR B 307
CYH B 319
CYH B 321
 SAM  B 402 (-3.1A)
SAM  B 402 (-4.5A)
539  B 403 ( 3.9A)
ZN  B 401 ( 2.3A)
ZN  B 401 ( 2.2A)
 0.87A 6agoA-5cprB:
7.8		 6agoA-5cprB:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f59 HISTONE-LYSINE
N-METHYLTRANSFERASE
2C

(Homo sapiens) 		PF00856
(SET) 		6 GLY A4782
TYR A4825
ASN A4848
HIS A4849
TYR A4886
CYH A4899
 SAH  A5002 (-3.5A)
SAH  A5002 (-4.5A)
SAH  A5002 (-2.7A)
SAH  A5002 (-4.6A)
None
ZN  A5001 ( 2.0A)
 1.46A 6agoA-5f59A:
15.8		 6agoA-5f59A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f59 HISTONE-LYSINE
N-METHYLTRANSFERASE
2C

(Homo sapiens) 		PF00856
(SET) 		7 GLY A4782
TYR A4825
ASN A4848
HIS A4849
TYR A4886
CYH A4899
CYH A4901
 SAH  A5002 (-3.5A)
SAH  A5002 (-4.5A)
SAH  A5002 (-2.7A)
SAH  A5002 (-4.6A)
None
ZN  A5001 ( 2.0A)
ZN  A5001 (-2.3A)
 0.88A 6agoA-5f59A:
15.8		 6agoA-5f59A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f59 HISTONE-LYSINE
N-METHYLTRANSFERASE
2C

(Homo sapiens) 		PF00856
(SET) 		5 GLY A4784
TYR A4825
HIS A4849
TYR A4886
CYH A4901
 None
SAH  A5002 (-4.5A)
SAH  A5002 (-4.6A)
None
ZN  A5001 (-2.3A)
 1.43A 6agoA-5f59A:
15.8		 6agoA-5f59A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f6l HISTONE-LYSINE
N-METHYLTRANSFERASE
2A

(Homo sapiens) 		PF00856
(SET) 		6 GLY A3840
ASN A3906
HIS A3907
TYR A3944
CYH A3957
CYH A3959
 SAH  A4001 (-3.4A)
SAH  A4001 (-3.0A)
SAH  A4001 (-4.9A)
SAH  A4001 (-4.9A)
ZN  A4002 ( 2.3A)
ZN  A4002 (-2.3A)
 0.81A 6agoA-5f6lA:
15.6		 6agoA-5f6lA:
24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f6l HISTONE-LYSINE
N-METHYLTRANSFERASE
2A

(Homo sapiens) 		PF00856
(SET) 		5 GLY A3842
HIS A3907
TYR A3944
CYH A3957
CYH A3959
 None
SAH  A4001 (-4.9A)
SAH  A4001 (-4.9A)
ZN  A4002 ( 2.3A)
ZN  A4002 (-2.3A)
 1.35A 6agoA-5f6lA:
15.6		 6agoA-5f6lA:
24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f6l HISTONE-LYSINE
N-METHYLTRANSFERASE
2A

(Homo sapiens) 		PF00856
(SET) 		5 TYR A3883
HIS A3907
TYR A3944
CYH A3957
CYH A3959
 None
SAH  A4001 (-4.9A)
SAH  A4001 (-4.9A)
ZN  A4002 ( 2.3A)
ZN  A4002 (-2.3A)
 0.73A 6agoA-5f6lA:
15.6		 6agoA-5f6lA:
24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  16
ASN A 206
HIS A 207
TYR A 240
CYH A 262
 None
SAM  A 501 (-3.2A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
 1.36A 6agoA-5kjmA:
6.3		 6agoA-5kjmA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  16
HIS A 207
TYR A 240
CYH A 262
CYH A 264
 None
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
ZN  A 505 (-2.4A)
 1.11A 6agoA-5kjmA:
6.3		 6agoA-5kjmA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  18
ASN A 206
HIS A 207
TYR A 240
CYH A 262
 SAM  A 501 ( 4.1A)
SAM  A 501 (-3.2A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
 1.03A 6agoA-5kjmA:
6.3		 6agoA-5kjmA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  18
ASN A 206
HIS A 207
TYR A 240
CYH A 262
 SAM  A 501 ( 4.1A)
SAM  A 501 (-3.2A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
 1.29A 6agoA-5kjmA:
6.3		 6agoA-5kjmA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ls6 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2

(Homo sapiens) 		PF00856
(SET)
PF11616
(EZH2_WD-Binding) 		5 GLY A 623
TRP A 624
ASN A 688
HIS A 689
TYR A 726
 74D  A 809 ( 3.9A)
None
74D  A 809 (-3.0A)
None
None
 0.85A 6agoA-5ls6A:
18.0		 6agoA-5ls6A:
17.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		7 GLY A1074
TRP A1075
ASN A1141
HIS A1142
TYR A1179
CYH A1191
CYH A1193
 SAM  A1304 ( 3.2A)
None
SAM  A1304 (-2.9A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 ( 2.3A)
ZN  A1301 (-2.3A)
 0.83A 6agoA-5lsuA:
25.3		 6agoA-5lsuA:
38.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		7 GLY A1074
TYR A1118
ASN A1141
HIS A1142
TYR A1179
CYH A1191
CYH A1193
 SAM  A1304 ( 3.2A)
SAM  A1304 (-3.8A)
SAM  A1304 (-2.9A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 ( 2.3A)
ZN  A1301 (-2.3A)
 0.88A 6agoA-5lsuA:
25.3		 6agoA-5lsuA:
38.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A1076
TYR A1118
HIS A1142
TYR A1179
CYH A1193
 SAM  A1304 ( 4.6A)
SAM  A1304 (-3.8A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 (-2.3A)
 1.36A 6agoA-5lsuA:
25.3		 6agoA-5lsuA:
38.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5teg N-LYSINE
METHYLTRANSFERASE
KMT5A

(Homo sapiens) 		PF00856
(SET) 		5 GLY A 227
TYR A 271
ASN A 298
HIS A 299
TYR A 336
 SAM  A 401 ( 4.0A)
SAM  A 401 (-4.1A)
SAM  A 401 (-3.2A)
None
SAM  A 401 (-4.8A)
 0.99A 6agoA-5tegA:
13.6		 6agoA-5tegA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuy HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A1049
TRP A1050
ASN A1112
HIS A1113
TYR A1154
CYH A1168
 SAM  A1505 ( 3.9A)
None
SAM  A1505 (-3.4A)
SAM  A1505 (-4.7A)
SAM  A1505 (-4.9A)
ZN  A1504 (-2.2A)
 1.36A 6agoA-5tuyA:
18.0		 6agoA-5tuyA:
26.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuy HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1049
TRP A1050
ASN A1112
HIS A1113
TYR A1154
CYH A1168
CYH A1170
 SAM  A1505 ( 3.9A)
None
SAM  A1505 (-3.4A)
SAM  A1505 (-4.7A)
SAM  A1505 (-4.9A)
ZN  A1504 (-2.2A)
ZN  A1504 (-2.2A)
 0.80A 6agoA-5tuyA:
18.0		 6agoA-5tuyA:
26.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuy HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1049
TYR A1085
ASN A1112
HIS A1113
TYR A1154
CYH A1168
CYH A1170
 SAM  A1505 ( 3.9A)
SAM  A1505 (-4.0A)
SAM  A1505 (-3.4A)
SAM  A1505 (-4.7A)
SAM  A1505 (-4.9A)
ZN  A1504 (-2.2A)
ZN  A1504 (-2.2A)
 0.89A 6agoA-5tuyA:
18.0		 6agoA-5tuyA:
26.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A1137
TRP A1138
ASN A1200
HIS A1201
CYH A1256
 SAM  A3001 (-3.6A)
None
SAM  A3001 (-3.4A)
SAM  A3001 (-4.6A)
ZN  A3005 ( 2.4A)
 1.34A 6agoA-5vsdA:
18.2		 6agoA-5vsdA:
27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1137
TRP A1138
ASN A1200
HIS A1201
TYR A1242
CYH A1256
CYH A1258
 SAM  A3001 (-3.6A)
None
SAM  A3001 (-3.4A)
SAM  A3001 (-4.6A)
SAM  A3001 (-4.8A)
ZN  A3005 ( 2.4A)
ZN  A3005 (-2.3A)
 0.85A 6agoA-5vsdA:
18.2		 6agoA-5vsdA:
27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1137
TYR A1173
ASN A1200
HIS A1201
TYR A1242
CYH A1256
CYH A1258
 SAM  A3001 (-3.6A)
SAM  A3001 (-4.0A)
SAM  A3001 (-3.4A)
SAM  A3001 (-4.6A)
SAM  A3001 (-4.8A)
ZN  A3005 ( 2.4A)
ZN  A3005 (-2.3A)
 0.94A 6agoA-5vsdA:
18.2		 6agoA-5vsdA:
27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wg6 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,POLYCOMB
PROTEIN SUZ12
(E.C.2.1.1.43)
CHIMERA

(Homo sapiens) 		no annotation 5 GLY A 623
TRP A 624
ASN A 688
HIS A 689
TYR A 726
 A9G  A9009 ( 4.2A)
None
A9G  A9009 (-3.1A)
None
None
 0.88A 6agoA-5wg6A:
18.8		 6agoA-5wg6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xxg -

(-) 		no annotation 5 GLY A  15
ASN A 205
HIS A 206
TYR A 239
CYH A 261
 SAM  A 502 ( 3.9A)
SAM  A 502 (-3.1A)
None
8HR  A 501 ( 4.0A)
ZN  A 503 (-2.2A)
 1.09A 6agoA-5xxgA:
6.3		 6agoA-5xxgA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 6 GLY A1156
TRP A1157
HIS A1224
TYR A1261
CYH A1273
CYH A1275
 SAM  A1301 (-3.6A)
None
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
ZN  A1304 (-2.3A)
 0.65A 6agoA-6cenA:
24.7		 6agoA-6cenA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 6 GLY A1156
TYR A1200
HIS A1224
TYR A1261
CYH A1273
CYH A1275
 SAM  A1301 (-3.6A)
SAM  A1301 (-3.9A)
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
ZN  A1304 (-2.3A)
 0.69A 6agoA-6cenA:
24.7		 6agoA-6cenA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 6 TRP A1157
ASN A1223
HIS A1224
TYR A1261
CYH A1273
CYH A1275
 None
SAM  A1301 (-3.2A)
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
ZN  A1304 (-2.3A)
 0.87A 6agoA-6cenA:
24.7		 6agoA-6cenA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 6 TYR A1200
ASN A1223
HIS A1224
TYR A1261
CYH A1273
CYH A1275
 SAM  A1301 (-3.9A)
SAM  A1301 (-3.2A)
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
ZN  A1304 (-2.3A)
 0.92A 6agoA-6cenA:
24.7		 6agoA-6cenA:
undetectable